Close Menu

WHO

Thermo Fisher Scientific said this week it has acquired the exclusive rights from diagnostics firm Nephromics to use placental growth factor protein as a biomarker for the diagnosis of preeclampsia and eclampsia.

Researchers used the PacBio system to sequence the O104;H4 strain of Escherichia coli responsible for a recent outbreak in Europe that resulted in thousands of illnesses and more than 50 deaths.

In addition to citing performance issues of antibody-based blood tests for TB, WHO said that such tests are targeted at countries "with weak regulatory mechanisms."

The World Health Organization has started a new effort to seek input from the world scientific community to identify genomics and public health challenges in developing countries.

On the heels of a 19 percent spike in fourth-quarter revenues and a quarterly profit, Cepheid said that it will receive $5 million from the Foundation for Innovative New Diagnostics to help accelerate development of a molecular test for HIV viral load.

WHO is now calling for the fully-automated nucleic acid amplification test to be rolled out under defined conditions as part of national plans for TB and multi-drug resistant TB care and control.

"We believe this is an ultimate tool for monitoring the genetic stability of all viral vaccines — not only live, but also inactivated vaccines," Konstantin Chumakov, associate director for research at the FDA's Office of Vaccines Research and Review, told In Sequence.

Pages

A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.